Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gehan

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cancer|August 1, 1972
Combination chemotherapy for multiple myelomaR Alexanian, J Bonnet, E Gehan, et al.
Journal of Pediatric Hematology/Oncology|November 1, 1995
Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and responseF B Ruymann, T Vietti, E Gehan, et al.
JAMA|November 19, 1982
Improved prospects for long-term survival in adults with acute myelogenous leukemiaM J Keating, K B McCredie, G P Bodey, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1996
Parameningeal rhabdomyosarcoma: results of an international workshopV Benk, C Rodary, S S Donaldson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 1992
Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study CommitteeR Heyn, R B Raney, D M Hays, et al.
Journal of Hematotherapy & Stem Cell Research|May 22, 2001
Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunotherapyK R Meehan, A Wu, R Hassan, et al.
JAMA|March 8, 1976
Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapyG P Bodey, E J Freireich, E Gehan, et al.
AIDS Research|January 1, 1986
Effect of azimexon therapy on host defense parameters and disease-associated symptoms in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC)Y Z Patt, P W Mansell, J M Reuben, et al.
Cancer|June 15, 1980
Radiation to regional nodes for rhabdomyosarcoma of the genitourinary tract in children: is it necessary? A report from the Intergroup Rhabdomyosarcoma Study No. 1 (IRS-1)M Tefft, D Hays, R B Raney, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1985
Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bonesR Evans, M Nesbit, F Askin, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cancer|August 1, 1972
Combination chemotherapy for multiple myelomaR Alexanian, J Bonnet, E Gehan, et al.
Journal of Pediatric Hematology/Oncology|November 1, 1995
Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and responseF B Ruymann, T Vietti, E Gehan, et al.
JAMA|November 19, 1982
Improved prospects for long-term survival in adults with acute myelogenous leukemiaM J Keating, K B McCredie, G P Bodey, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1996
Parameningeal rhabdomyosarcoma: results of an international workshopV Benk, C Rodary, S S Donaldson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 1992
Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study CommitteeR Heyn, R B Raney, D M Hays, et al.
Journal of Hematotherapy & Stem Cell Research|May 22, 2001
Ex vivo cytokine activation of peripheral blood stem cells: a potential role for adoptive cellular immunotherapyK R Meehan, A Wu, R Hassan, et al.
JAMA|March 8, 1976
Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapyG P Bodey, E J Freireich, E Gehan, et al.
AIDS Research|January 1, 1986
Effect of azimexon therapy on host defense parameters and disease-associated symptoms in the acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC)Y Z Patt, P W Mansell, J M Reuben, et al.
Cancer|June 15, 1980
Radiation to regional nodes for rhabdomyosarcoma of the genitourinary tract in children: is it necessary? A report from the Intergroup Rhabdomyosarcoma Study No. 1 (IRS-1)M Tefft, D Hays, R B Raney, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1985
Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bonesR Evans, M Nesbit, F Askin, et al.
Pageof 4